The global extracellular matrix patches market revenue was around US$ 27.14 million in 2022 and is estimated to reach US$ 55.1 million by 2031, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period from 2023 to 2031.
Extracellular matrix (ECM) patches are sometimes referred to as ECM grafts or matrices. They are materials or medical devices utilized in tissue engineering and regenerative medicine. The extracellular matrix provides a framework for the regeneration, repair, and reconstruction of wounded or damaged human tissues, It can be synthesized or naturally occurring. The non-cellular component of tissue called extracellular matrix (ECM) gives the surrounding cells structural and metabolic support.
Market Driving Factors
The increasing use of extracellular matrix (ECM) in pelvic and hernia reconstruction surgeries is fueling the market for these products. Abdominal wall hernia surgeries are among the most typical procedures globally. As a result, various companies are dedicated to creating extracellular matrix products for hernia repair and pelvic reconstruction.
Technological advancement in the extracellular matrix for wound healing procedures and soft tissue repair is increasing the demand for these products. For instance, AltiPly was developed by Aziyo Biologics. AltiPly is a ready-to-use patch that does not require rehydration and is easy to handle at room temperature. It finds applications in treating conditions like venous leg ulcers, diabetic foot ulcers, and pressure wounds. The proprietary processing of AltiPly enhances growth factors and accelerates the healing process.
The increased costs linked to ECM grafts may hamper the market growth.
Regional Analysis
Asia Pacific dominated the market in terms of the fastest rate. This can be attributed to the surge in trauma cases, the high prevalence of cardiovascular diseases, and the rise in the number of surgeries. In addition, increasing disease burden and escalating healthcare expenditure are estimated to boost the demand in the region.
North America dominates the market in terms of revenue. This is because escalating prevalence of cardiovascular defects, diseases, trauma cases, and sports-related injuries. For instance, in August 2023, the National Institute of Health (NIH) highlighted that half of Americans aged 45 to 84 have atherosclerosis. Furthermore, the existence of numerous market participants enhances the accessibility and availability of ECM patches in this region. In addition, the presence of cutting-edge research facilities, substantial research funding, and effective healthcare expenditure drives the region growth.
Segmentation Insights
Raw Material Insight
The bovine segment dominates the market. This is due to the surging availability of bovine-based products and their extending applications in vascular repair, pericardial repair, dural repair, soft tissue repair, and other medical procedures that have boosted their demand. In addition, these patches are favored over alternative materials owing to their superior biocompatibility, ease of handling in surgeries, and low infection risk. Moreover, the large supply of cattle and their comparatively lower price are driving segment growth.
The porcine segment held the largest share of the market. This is due to its vast utilization in reconstructive and repair surgeries. These grafts, derived from pigs, are like human collagen, decreasing the chance of allergic reactions. They provide advantages like flexibility, durability, and minimal scarring, enhancing their demand. In addition, their high adoption rates and widespread availability contribute significantly to the segment growth.
Application Insight
The vascular repair and reconstruction segment is expected to dominate the market in terms of the fastest rate. This is because the increasing number of vascular surgeries, the surge in prevalence of vascular diseases, and the rising geriatric population are among the crucial elements expected to increase demand.
The soft tissue repair segment dominated the market in terms of revenue share. This can be attributed to the surge in the number of hernia repair surgeries–especially inguinal hernia, a rise in trauma surgeries prevalence, and increased treatment rates. Additionally, the surge in adoption and awareness of the extracellular matrix among healthcare providers, mainly in developed nations is expected to boost the segment.
Prominent Companies
Segmentation Outline
The global extracellular matrix patches market segmentation focuses on Raw Material, Application, and Region.
By Raw Material
By Application
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL EXTRACELLULAR MATRIX PATCHES MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: EXTRACELLULAR MATRIX PATCHES MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL EXTRACELLULAR MATRIX PATCHES MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL EXTRACELLULAR MATRIX PATCHES MARKET, BY RAW MATERIAL
5.1 OVERVIEW
5.2 BOVINE
5.3 PORCINE
5.4 OTHERS
6 GLOBAL EXTRACELLULAR MATRIX PATCHES MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 CARDIAC REPAIR
6.3 VASCULAR REPAIR & RECONSTRUCTION
6.4 PERICARDIAL REPAIR
6.5 DURAL REPAIR
6.6 SOFT TISSUE REPAIR
6.7 WOUND HEALING
7 GLOBAL EXTRACELLULAR MATRIX PATCHES MARKET, BY GEOGRAPHY
7.1 OVERVIEW
7.2 NORTH AMERICA
7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO
7.3 EUROPE
7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3.1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE
7.4 ASIA PACIFIC
7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC
7.5 MIDDLE EAST & AFRICA
7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA
7.6 SOUTH AMERICA
7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA
8 GLOBAL EXTRACELLULAR MATRIX PATCHES MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES
8.4 COMPETITIVE DASHBOARD
8.5 PRODUCT MAPPING
8.6 TOP PLAYER POSITIONING, 2022
8.7 COMPETITIVE HEATMAP
8.8 TOP WINNING STRATEGIES
9 COMPANY PROFILES
9.1 COOK GROUP
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS
9.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.2 COLOPLAST GROUP
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS
9.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.3 SMITH & NEPHEW
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS
9.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.4 KONINKLIJKE DSM N.V.
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS
9.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.5 MTF BIOLOGICS
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS
9.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.6 AROA BIOSURGERY
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS
9.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.7 MEDTRONIC
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS
9.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.8 BAXTER
9.8.1 OVERVIEW
9.8.2 FINANCIAL PERFORMANCE
9.8.3 PRODUCT OUTLOOK
9.8.4 KEY DEVELOPMENTS
9.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.9 AZIYO BIOLOGICS
9.9.1 OVERVIEW
9.9.2 FINANCIAL PERFORMANCE
9.9.3 PRODUCT OUTLOOK
9.9.4 KEY DEVELOPMENTS
9.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.10 INTEGRA LIFE SCIENCES
9.10.1 OVERVIEW
9.10.2 FINANCIAL PERFORMANCE
9.10.3 PRODUCT OUTLOOK
9.10.4 KEY DEVELOPMENTS
9.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved